The Data Transparency Autumn Event 2025 brought together 519 attendees spanning 140 companies and 25 countries. With discussions on evolving policies, the ethical responsibilities of data sharing, the challenges of privacy and risk management, and AI and innovation, the event offered a rich mix of perspectives and expertise, with Q&A sessions fueling thought-provoking discussions.

Category: Events Across the Globe

Quality by Design (QbD) is a systematic approach to product development, particularly in pharmaceuticals and clinical trials, aimed at ensuring that quality is built into the design, conduct and monitoring of a study from the outset. The ICH E6(R3) Good Clinical Practice (GCP) guideline introduces a framework that promotes flexibility in study conduct, modernisation of trial approaches, and greater efficiency in clinical trial execution. Statistical elements are central to achieving these objectives.

Category: Industry Topics

The demand for data scientists has increased by 56% in recent years, with global data volumes set to reach 175 zettabytes this year. This has created a ‘perfect storm’ of sorts for those entering the field, but standing out in the late 2020s is becoming increasingly difficult.

Category: Industry Topics

Discover the content of two record-breaking webinars, hosted by the Real World Data Working Group, which provided practical insights into how estimands and target trial emulation frameworks are reshaping the design and interpretation of real-world evidence (RWE) studies.

Category: Working Groups News